Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Dr. Christopher Missling CEO Anavex Discussing current state of research into neurodegenerative disorders, such as Alzheimer's disease and Parkinson’s, and Anavex’s approach with ANAVEX 2-73. Caroline Hyde of Bloomberg Television also participates in the conversation.

OpenAI Reports New AI Safety Incidents, Sets Disclosure Plan
34:39

College Sports Go Pro on Player Pay, Arenas, $50 Million Coaches
11:13

Space, Robotics, and the Next Investment Boom
12:37